GPC3 and hepatocellular carcinoma: Yu et al. investigated that anti-glypican-3 (GPC3)-CAR-NK cells against HCC cells induced significantly in vitro cytotoxicity and cytokine release, as well as antitumor in vivo effects in HCC xenograft models [206].